Global Seasonal Influenza Vaccines Market Report 2020 - FDA Clears CDC Diagnostic For COVID-19 And Influenza
ResearchAndMarkets.coms offering. The seasonal influenza vaccines market in the US, Japan, and five major European markets (France, Germany, Italy, Spain, and the UK) is expected to continue to expand over the next 10 years, largely due to the continued uptake of premium-priced vaccines in the elderly subgroup, including quadrivalent forms of Fluzone High-Dose (HD) and Fluad, as well as the launch of the first-in-class adjuvanted nanoparticle vaccine, NanoFlu. Further to this, an aging populati...
United Kingdom Fluarix Flulaval Glaxosmithkline Afluria Agrippal Glaxosmithkline Fluarix Fluzone Vaxigrip Sanofi Seqirus Afluria
Source: prnewswire.com